Guillain-Barré Syndrome Quiz

Guillain-Barré Syndrome (GBS): Practice Guide for Exam-Style Questions

Guillain-Barré Syndrome (GBS) is a critical topic in neurology, frequently appearing on exams due to its acute nature and specific diagnostic and management pathways. This guide breaks down the core concepts you need to know to confidently answer questions about this post-infectious autoimmune polyradiculoneuropathy.

Pathophysiology: The Autoimmune Attack

The core mechanism of GBS is an autoimmune response targeting the peripheral nervous system. Following an infection, the body produces antibodies that cross-react with components of nerve sheaths (myelin) or the nerve axon itself. This molecular mimicry leads to demyelination and/or axonal damage, disrupting nerve signal transmission.

Clinical Presentation: Ascending Weakness

The classic presentation is a rapidly progressive, relatively symmetrical ascending weakness. It often begins in the lower extremities and travels upwards over hours to days. Areflexia (loss of deep tendon reflexes) is a hallmark sign. Sensory symptoms like paresthesia are common but are typically less prominent than the motor weakness.

Diagnostic Workup: Piecing Together the Clues

Diagnosis is primarily clinical, supported by ancillary tests. Exam questions will often present a clinical vignette and ask for the next best step. Key diagnostic tools include lumbar puncture for CSF analysis and electrodiagnostic studies (nerve conduction studies/EMG) which can show evidence of demyelination.

Common Antecedent Triggers

A history of a preceding infection one to four weeks prior to symptom onset is found in about two-thirds of cases. Knowing the most common triggers is essential for multiple-choice questions.

• Campylobacter jejuni: The most frequent trigger, often associated with a more severe, axonal form of GBS.
• Cytomegalovirus (CMV)
• Epstein-Barr Virus (EBV)
• Mycoplasma pneumoniae
• Zika Virus
• Influenza and other respiratory infections

Treatment Modalities: IVIg and Plasmapheresis

The mainstays of treatment are immunomodulatory therapies aimed at removing or neutralizing the harmful autoantibodies. For patients who cannot ambulate independently, prompt treatment is crucial. The two primary, equally effective options are Intravenous Immunoglobulin (IVIg) and Plasmapheresis (Plasma Exchange). Corticosteroids have been proven ineffective and are not recommended.

Management of Complications: Respiratory and Autonomic Failure

A major cause of morbidity and mortality is respiratory failure due to paralysis of the diaphragm. Close monitoring of respiratory function is paramount. Autonomic dysfunction can also occur, leading to dangerous fluctuations in heart rate and blood pressure.

• Forced Vital Capacity (FVC) measurement
• Negative Inspiratory Force (NIF) monitoring
• Continuous cardiac and blood pressure monitoring
• Prophylaxis for deep vein thrombosis (DVT)
• Management of pain and dysphagia
• Bladder and bowel care

Clinical Variants: Miller Fisher Syndrome

Be aware of GBS variants. The most tested is Miller Fisher Syndrome (MFS), characterized by the classic triad of ophthalmoplegia (eye muscle weakness), ataxia (imbalance), and areflexia. Unlike classic GBS, the weakness in MFS is often descending.

Key Takeaways for Exam Success

• Hallmark Sign: Symmetrical, ascending muscle weakness with areflexia.
• Primary Trigger: Campylobacter jejuni gastroenteritis.
• Key Lab Finding: High protein with normal cells in CSF (albuminocytologic dissociation).
• First-Line Treatments: IVIg or Plasmapheresis. Avoid corticosteroids.
• Critical Complication: Respiratory failure requiring vigilant monitoring of breathing capacity.

This content is for informational and educational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified health provider with any questions you may have regarding a medical condition.